Structure

Physi-Chem Properties

Molecular Weight:  518.4
Volume:  566.48
LogP:  4.653
LogD:  3.928
LogS:  -4.779
# Rotatable Bonds:  7
TPSA:  86.99
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.369
Synthetic Accessibility Score:  5.255
Fsp3:  0.906
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.234
MDCK Permeability:  1.2851179235440213e-05
Pgp-inhibitor:  0.991
Pgp-substrate:  0.094
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.962
30% Bioavailability (F30%):  0.935

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.257
Plasma Protein Binding (PPB):  92.4027328491211%
Volume Distribution (VD):  1.002
Pgp-substrate:  2.2002480030059814%

ADMET: Metabolism

CYP1A2-inhibitor:  0.005
CYP1A2-substrate:  0.589
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.942
CYP2C9-inhibitor:  0.094
CYP2C9-substrate:  0.204
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.101
CYP3A4-inhibitor:  0.781
CYP3A4-substrate:  0.756

ADMET: Excretion

Clearance (CL):  6.975
Half-life (T1/2):  0.214

ADMET: Toxicity

hERG Blockers:  0.032
Human Hepatotoxicity (H-HT):  0.278
Drug-inuced Liver Injury (DILI):  0.037
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.55
Maximum Recommended Daily Dose:  0.714
Skin Sensitization:  0.09
Carcinogencity:  0.399
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.978

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473166

Natural Product ID:  NPC473166
Common Name*:   QVVRXENOONWNGX-IPAXGOGQSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  QVVRXENOONWNGX-IPAXGOGQSA-N
Standard InCHI:  InChI=1S/C32H54O5/c1-10-37-29(5,6)27(36)23(34)17-19(2)20-11-15-31(8)21(20)18-22(33)26-30(7)14-13-25(35)28(3,4)24(30)12-16-32(26,31)9/h19,22-24,26-27,33-34,36H,10-18H2,1-9H3/t19-,22+,23+,24+,26+,27-,30+,31+,32+/m1/s1
SMILES:  CCOC(C)(C)C(C(CC(C)C1=C2CC(C3C4(CCC(=O)C(C4CCC3(C2(CC1)C)C)(C)C)C)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3632946
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30648 Alisma orientale Species Alismataceae Eukaryota rhizome n.a. n.a. PMID[10560729]
NPO30648 Alisma orientale Species Alismataceae Eukaryota n.a. rhizome n.a. PMID[17541191]
NPO30648 Alisma orientale Species Alismataceae Eukaryota Rhizome n.a. n.a. PMID[26425784]
NPO30648 Alisma orientale Species Alismataceae Eukaryota n.a. tuber n.a. PMID[26666273]
NPO30648 Alisma orientale Species Alismataceae Eukaryota n.a. n.a. n.a. Database[HerDing]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT203 Individual Protein Carboxylesterase 2 Homo sapiens IC50 = 4720.0 nM PMID[528444]
NPT540 Individual Protein Bile acid receptor FXR Homo sapiens EC50 = 940.0 nM PMID[528445]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473166 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9659 High Similarity NPC37787
0.9659 High Similarity NPC180557
0.9659 High Similarity NPC473415
0.9659 High Similarity NPC469329
0.9659 High Similarity NPC30677
0.9655 High Similarity NPC274046
0.9655 High Similarity NPC198074
0.9529 High Similarity NPC469314
0.9529 High Similarity NPC469317
0.9529 High Similarity NPC241875
0.9333 High Similarity NPC471777
0.913 High Similarity NPC303777
0.913 High Similarity NPC471784
0.908 High Similarity NPC469322
0.9059 High Similarity NPC86370
0.9043 High Similarity NPC469316
0.8947 High Similarity NPC324001
0.8936 High Similarity NPC469327
0.8901 High Similarity NPC240617
0.8889 High Similarity NPC473167
0.8876 High Similarity NPC229871
0.8876 High Similarity NPC469319
0.8737 High Similarity NPC476897
0.871 High Similarity NPC471822
0.8673 High Similarity NPC471783
0.8673 High Similarity NPC469318
0.8673 High Similarity NPC9457
0.8673 High Similarity NPC473173
0.8632 High Similarity NPC473176
0.8602 High Similarity NPC473170
0.8571 High Similarity NPC470587
0.8485 Intermediate Similarity NPC473165
0.8462 Intermediate Similarity NPC250592
0.8462 Intermediate Similarity NPC77263
0.8462 Intermediate Similarity NPC32830
0.8444 Intermediate Similarity NPC138756
0.8387 Intermediate Similarity NPC469315
0.8384 Intermediate Similarity NPC472655
0.8367 Intermediate Similarity NPC471005
0.8333 Intermediate Similarity NPC471737
0.8317 Intermediate Similarity NPC41405
0.8315 Intermediate Similarity NPC473157
0.8298 Intermediate Similarity NPC67831
0.8298 Intermediate Similarity NPC174051
0.828 Intermediate Similarity NPC155304
0.828 Intermediate Similarity NPC262870
0.8242 Intermediate Similarity NPC90652
0.8235 Intermediate Similarity NPC470065
0.8235 Intermediate Similarity NPC5284
0.8229 Intermediate Similarity NPC272451
0.8222 Intermediate Similarity NPC197823
0.8211 Intermediate Similarity NPC279974
0.8182 Intermediate Similarity NPC239716
0.8182 Intermediate Similarity NPC264048
0.8172 Intermediate Similarity NPC136801
0.8163 Intermediate Similarity NPC233012
0.8163 Intermediate Similarity NPC54909
0.8152 Intermediate Similarity NPC474677
0.8152 Intermediate Similarity NPC470417
0.8152 Intermediate Similarity NPC193360
0.8144 Intermediate Similarity NPC470067
0.8144 Intermediate Similarity NPC470068
0.8144 Intermediate Similarity NPC470066
0.8144 Intermediate Similarity NPC119036
0.8137 Intermediate Similarity NPC218853
0.8125 Intermediate Similarity NPC230151
0.8125 Intermediate Similarity NPC91439
0.8105 Intermediate Similarity NPC159410
0.8105 Intermediate Similarity NPC318332
0.81 Intermediate Similarity NPC75531
0.81 Intermediate Similarity NPC149124
0.8085 Intermediate Similarity NPC235704
0.8081 Intermediate Similarity NPC473163
0.8077 Intermediate Similarity NPC234042
0.8077 Intermediate Similarity NPC470063
0.8077 Intermediate Similarity NPC152117
0.8065 Intermediate Similarity NPC122116
0.8065 Intermediate Similarity NPC474245
0.8065 Intermediate Similarity NPC31985
0.8065 Intermediate Similarity NPC1015
0.8061 Intermediate Similarity NPC167974
0.8058 Intermediate Similarity NPC250956
0.8041 Intermediate Similarity NPC474785
0.8041 Intermediate Similarity NPC474938
0.8021 Intermediate Similarity NPC200702
0.802 Intermediate Similarity NPC475414
0.802 Intermediate Similarity NPC173172
0.8 Intermediate Similarity NPC107674
0.8 Intermediate Similarity NPC141497
0.8 Intermediate Similarity NPC170220
0.8 Intermediate Similarity NPC255017
0.8 Intermediate Similarity NPC86368
0.798 Intermediate Similarity NPC473174
0.798 Intermediate Similarity NPC470054
0.7979 Intermediate Similarity NPC473269
0.7979 Intermediate Similarity NPC471896
0.7979 Intermediate Similarity NPC126993
0.7979 Intermediate Similarity NPC85173
0.7961 Intermediate Similarity NPC475065
0.7961 Intermediate Similarity NPC472216
0.7961 Intermediate Similarity NPC5475
0.7961 Intermediate Similarity NPC284828
0.7961 Intermediate Similarity NPC173905
0.7957 Intermediate Similarity NPC44181
0.7957 Intermediate Similarity NPC230387
0.7941 Intermediate Similarity NPC144459
0.7941 Intermediate Similarity NPC475176
0.7941 Intermediate Similarity NPC473284
0.7941 Intermediate Similarity NPC255387
0.7941 Intermediate Similarity NPC131665
0.7938 Intermediate Similarity NPC327179
0.7938 Intermediate Similarity NPC120708
0.7938 Intermediate Similarity NPC327788
0.7935 Intermediate Similarity NPC325594
0.7935 Intermediate Similarity NPC73038
0.7935 Intermediate Similarity NPC56588
0.7935 Intermediate Similarity NPC213412
0.7921 Intermediate Similarity NPC471293
0.7917 Intermediate Similarity NPC473172
0.7917 Intermediate Similarity NPC296164
0.7912 Intermediate Similarity NPC59453
0.7912 Intermediate Similarity NPC221758
0.79 Intermediate Similarity NPC470053
0.79 Intermediate Similarity NPC473928
0.79 Intermediate Similarity NPC296879
0.79 Intermediate Similarity NPC477054
0.79 Intermediate Similarity NPC471119
0.7895 Intermediate Similarity NPC285184
0.7895 Intermediate Similarity NPC86266
0.7895 Intermediate Similarity NPC26888
0.7895 Intermediate Similarity NPC77099
0.7895 Intermediate Similarity NPC212301
0.7895 Intermediate Similarity NPC470590
0.7895 Intermediate Similarity NPC110657
0.7895 Intermediate Similarity NPC60755
0.7895 Intermediate Similarity NPC189520
0.7889 Intermediate Similarity NPC151519
0.7889 Intermediate Similarity NPC212083
0.7885 Intermediate Similarity NPC154856
0.7885 Intermediate Similarity NPC475317
0.7885 Intermediate Similarity NPC52241
0.7879 Intermediate Similarity NPC83709
0.7872 Intermediate Similarity NPC474889
0.7872 Intermediate Similarity NPC469323
0.7872 Intermediate Similarity NPC475921
0.7872 Intermediate Similarity NPC30522
0.7872 Intermediate Similarity NPC119416
0.7872 Intermediate Similarity NPC474704
0.7864 Intermediate Similarity NPC472218
0.7864 Intermediate Similarity NPC473482
0.7864 Intermediate Similarity NPC318363
0.7864 Intermediate Similarity NPC475418
0.7864 Intermediate Similarity NPC472217
0.7864 Intermediate Similarity NPC258323
0.7864 Intermediate Similarity NPC472219
0.7857 Intermediate Similarity NPC9613
0.7857 Intermediate Similarity NPC259788
0.7857 Intermediate Similarity NPC247139
0.7857 Intermediate Similarity NPC255589
0.7857 Intermediate Similarity NPC170978
0.7849 Intermediate Similarity NPC475740
0.7849 Intermediate Similarity NPC251808
0.7849 Intermediate Similarity NPC99909
0.7849 Intermediate Similarity NPC474174
0.7849 Intermediate Similarity NPC73064
0.7843 Intermediate Similarity NPC477877
0.7843 Intermediate Similarity NPC475494
0.7835 Intermediate Similarity NPC195715
0.7835 Intermediate Similarity NPC473648
0.7835 Intermediate Similarity NPC32118
0.7826 Intermediate Similarity NPC470574
0.7826 Intermediate Similarity NPC133954
0.7822 Intermediate Similarity NPC191892
0.7822 Intermediate Similarity NPC55954
0.7822 Intermediate Similarity NPC222153
0.7822 Intermediate Similarity NPC218513
0.7812 Intermediate Similarity NPC477436
0.7812 Intermediate Similarity NPC477435
0.7812 Intermediate Similarity NPC307335
0.7812 Intermediate Similarity NPC474806
0.7812 Intermediate Similarity NPC136313
0.7812 Intermediate Similarity NPC287118
0.7812 Intermediate Similarity NPC74855
0.7812 Intermediate Similarity NPC473690
0.7812 Intermediate Similarity NPC275809
0.7812 Intermediate Similarity NPC133579
0.7812 Intermediate Similarity NPC12722
0.7812 Intermediate Similarity NPC471902
0.7802 Intermediate Similarity NPC472743
0.7802 Intermediate Similarity NPC475726
0.7802 Intermediate Similarity NPC132635
0.78 Intermediate Similarity NPC115899
0.78 Intermediate Similarity NPC289670
0.78 Intermediate Similarity NPC477051
0.78 Intermediate Similarity NPC477053
0.78 Intermediate Similarity NPC477052
0.7789 Intermediate Similarity NPC148414
0.7789 Intermediate Similarity NPC111585
0.7789 Intermediate Similarity NPC120840
0.7789 Intermediate Similarity NPC111110

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473166 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7912 Intermediate Similarity NPD4786 Approved
0.7889 Intermediate Similarity NPD3667 Approved
0.7742 Intermediate Similarity NPD3618 Phase 1
0.7732 Intermediate Similarity NPD7748 Approved
0.7684 Intermediate Similarity NPD5328 Approved
0.7629 Intermediate Similarity NPD6399 Phase 3
0.757 Intermediate Similarity NPD8297 Approved
0.7526 Intermediate Similarity NPD8034 Phase 2
0.7526 Intermediate Similarity NPD6079 Approved
0.7526 Intermediate Similarity NPD7515 Phase 2
0.7526 Intermediate Similarity NPD8035 Phase 2
0.75 Intermediate Similarity NPD5739 Approved
0.75 Intermediate Similarity NPD7128 Approved
0.75 Intermediate Similarity NPD7902 Approved
0.75 Intermediate Similarity NPD6675 Approved
0.75 Intermediate Similarity NPD4755 Approved
0.75 Intermediate Similarity NPD6402 Approved
0.7473 Intermediate Similarity NPD7525 Registered
0.7455 Intermediate Similarity NPD7115 Discovery
0.7453 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7449 Intermediate Similarity NPD4202 Approved
0.7447 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD7320 Approved
0.7358 Intermediate Similarity NPD6899 Approved
0.7358 Intermediate Similarity NPD6881 Approved
0.7356 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD5286 Approved
0.7353 Intermediate Similarity NPD5285 Approved
0.7353 Intermediate Similarity NPD4700 Approved
0.7353 Intermediate Similarity NPD4696 Approved
0.734 Intermediate Similarity NPD3665 Phase 1
0.734 Intermediate Similarity NPD3666 Approved
0.734 Intermediate Similarity NPD3133 Approved
0.734 Intermediate Similarity NPD3668 Phase 3
0.7327 Intermediate Similarity NPD6084 Phase 2
0.7327 Intermediate Similarity NPD6083 Phase 2
0.7326 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD4753 Phase 2
0.7315 Intermediate Similarity NPD8130 Phase 1
0.729 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD6373 Approved
0.729 Intermediate Similarity NPD6372 Approved
0.7264 Intermediate Similarity NPD6412 Phase 2
0.7264 Intermediate Similarity NPD5701 Approved
0.7264 Intermediate Similarity NPD5697 Approved
0.7255 Intermediate Similarity NPD7638 Approved
0.7234 Intermediate Similarity NPD4788 Approved
0.7228 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD5222 Approved
0.7228 Intermediate Similarity NPD5221 Approved
0.7228 Intermediate Similarity NPD4697 Phase 3
0.7222 Intermediate Similarity NPD6883 Approved
0.7222 Intermediate Similarity NPD6117 Approved
0.7222 Intermediate Similarity NPD7102 Approved
0.7222 Intermediate Similarity NPD7290 Approved
0.7212 Intermediate Similarity NPD5211 Phase 2
0.7212 Intermediate Similarity NPD5224 Approved
0.7212 Intermediate Similarity NPD5225 Approved
0.7212 Intermediate Similarity NPD4633 Approved
0.7212 Intermediate Similarity NPD5226 Approved
0.72 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7900 Approved
0.7188 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD7640 Approved
0.7184 Intermediate Similarity NPD7639 Approved
0.7174 Intermediate Similarity NPD7645 Phase 2
0.7157 Intermediate Similarity NPD5173 Approved
0.7156 Intermediate Similarity NPD6650 Approved
0.7156 Intermediate Similarity NPD6617 Approved
0.7156 Intermediate Similarity NPD6869 Approved
0.7156 Intermediate Similarity NPD6649 Approved
0.7156 Intermediate Similarity NPD6847 Approved
0.7143 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5175 Approved
0.7143 Intermediate Similarity NPD6116 Phase 1
0.7143 Intermediate Similarity NPD5174 Approved
0.713 Intermediate Similarity NPD6013 Approved
0.713 Intermediate Similarity NPD6014 Approved
0.713 Intermediate Similarity NPD6012 Approved
0.7126 Intermediate Similarity NPD4267 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD5223 Approved
0.7111 Intermediate Similarity NPD3703 Phase 2
0.7091 Intermediate Similarity NPD6882 Approved
0.7087 Intermediate Similarity NPD4225 Approved
0.7075 Intermediate Similarity NPD5141 Approved
0.7065 Intermediate Similarity NPD3617 Approved
0.7065 Intermediate Similarity NPD6115 Approved
0.7065 Intermediate Similarity NPD6697 Approved
0.7065 Intermediate Similarity NPD6118 Approved
0.7065 Intermediate Similarity NPD6114 Approved
0.7064 Intermediate Similarity NPD4634 Approved
0.7048 Intermediate Similarity NPD7632 Discontinued
0.7045 Intermediate Similarity NPD4245 Approved
0.7045 Intermediate Similarity NPD4244 Approved
0.7041 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD6011 Approved
0.7027 Intermediate Similarity NPD4632 Approved
0.7011 Intermediate Similarity NPD5360 Phase 3
0.7011 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD7146 Approved
0.701 Intermediate Similarity NPD7334 Approved
0.701 Intermediate Similarity NPD5330 Approved
0.701 Intermediate Similarity NPD6684 Approved
0.701 Intermediate Similarity NPD7521 Approved
0.701 Intermediate Similarity NPD6409 Approved
0.7009 Intermediate Similarity NPD4768 Approved
0.7009 Intermediate Similarity NPD4767 Approved
0.7 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.6981 Remote Similarity NPD4754 Approved
0.6961 Remote Similarity NPD5695 Phase 3
0.6961 Remote Similarity NPD5210 Approved
0.6961 Remote Similarity NPD4629 Approved
0.6957 Remote Similarity NPD6054 Approved
0.6957 Remote Similarity NPD6319 Approved
0.6957 Remote Similarity NPD6059 Approved
0.6947 Remote Similarity NPD4223 Phase 3
0.6947 Remote Similarity NPD4221 Approved
0.6939 Remote Similarity NPD7524 Approved
0.6932 Remote Similarity NPD3698 Phase 2
0.6923 Remote Similarity NPD5696 Approved
0.6923 Remote Similarity NPD7339 Approved
0.6923 Remote Similarity NPD6942 Approved
0.6909 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6907 Remote Similarity NPD5329 Approved
0.6881 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6881 Remote Similarity NPD4729 Approved
0.6881 Remote Similarity NPD5128 Approved
0.6881 Remote Similarity NPD4730 Approved
0.6875 Remote Similarity NPD8133 Approved
0.6869 Remote Similarity NPD5737 Approved
0.6869 Remote Similarity NPD6672 Approved
0.6869 Remote Similarity NPD6903 Approved
0.6854 Remote Similarity NPD4789 Approved
0.6848 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6848 Remote Similarity NPD6933 Approved
0.6842 Remote Similarity NPD4692 Approved
0.6842 Remote Similarity NPD4139 Approved
0.6838 Remote Similarity NPD6370 Approved
0.6837 Remote Similarity NPD5279 Phase 3
0.6833 Remote Similarity NPD7736 Approved
0.6832 Remote Similarity NPD6411 Approved
0.6807 Remote Similarity NPD7507 Approved
0.6804 Remote Similarity NPD4197 Approved
0.6796 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6792 Remote Similarity NPD4159 Approved
0.678 Remote Similarity NPD8328 Phase 3
0.6757 Remote Similarity NPD5249 Phase 3
0.6757 Remote Similarity NPD5251 Approved
0.6757 Remote Similarity NPD5250 Approved
0.6757 Remote Similarity NPD5247 Approved
0.6757 Remote Similarity NPD5248 Approved
0.6754 Remote Similarity NPD6274 Approved
0.6752 Remote Similarity NPD6015 Approved
0.6752 Remote Similarity NPD6016 Approved
0.675 Remote Similarity NPD8293 Discontinued
0.6737 Remote Similarity NPD4748 Discontinued
0.6737 Remote Similarity NPD4695 Discontinued
0.6727 Remote Similarity NPD6686 Approved
0.6724 Remote Similarity NPD7100 Approved
0.6724 Remote Similarity NPD7101 Approved
0.6723 Remote Similarity NPD7492 Approved
0.6702 Remote Similarity NPD3671 Phase 1
0.6701 Remote Similarity NPD6695 Phase 3
0.6697 Remote Similarity NPD6008 Approved
0.6696 Remote Similarity NPD5217 Approved
0.6696 Remote Similarity NPD5215 Approved
0.6696 Remote Similarity NPD5216 Approved
0.6696 Remote Similarity NPD6009 Approved
0.6695 Remote Similarity NPD5988 Approved
0.6667 Remote Similarity NPD4690 Approved
0.6667 Remote Similarity NPD6616 Approved
0.6667 Remote Similarity NPD5205 Approved
0.6667 Remote Similarity NPD4138 Approved
0.6667 Remote Similarity NPD4623 Approved
0.6667 Remote Similarity NPD4688 Approved
0.6667 Remote Similarity NPD3171 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4519 Discontinued
0.6667 Remote Similarity NPD4689 Approved
0.6667 Remote Similarity NPD4693 Phase 3
0.6667 Remote Similarity NPD6098 Approved
0.6639 Remote Similarity NPD7319 Approved
0.6639 Remote Similarity NPD7604 Phase 2
0.6638 Remote Similarity NPD6335 Approved
0.6636 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6634 Remote Similarity NPD6080 Approved
0.6634 Remote Similarity NPD6904 Approved
0.6634 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6634 Remote Similarity NPD6101 Approved
0.6634 Remote Similarity NPD6673 Approved
0.6634 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6633 Remote Similarity NPD7338 Clinical (unspecified phase)
0.663 Remote Similarity NPD6926 Approved
0.663 Remote Similarity NPD6924 Approved
0.6612 Remote Similarity NPD7078 Approved
0.661 Remote Similarity NPD8033 Approved
0.661 Remote Similarity NPD5983 Phase 2
0.661 Remote Similarity NPD6909 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data